| BACKGROUND
Respiratory syncytial virus (RSV) is a major cause of respiratory tract infections (RTI) worldwide. 1 In older children and adults, RSV infection often leads to mild upper respiratory tract infection (URTI). However, in infants and young children, RSV is an important cause of severe respiratory infection, particularly bronchiolitis, which may require hospital admission. 2 With a number of RSV vaccine candidates now in phase 2 and 3 clinical trials, it is essential to have accurate estimates of the hospital burden of RSV by age and risk group in order to determine the potential benefits of a future vaccine programme. 3 Calculating the national burden of disease due to RSV is not straightforward. A reliable diagnosis of RSV infection relies on the detection of RSV in respiratory secretions, but only a minority of children hospitalised with an acute respiratory infection will undergo laboratory testing to identify the causal pathogen. 4 The vast majority of respiratory infections are therefore recorded in hospital admission data under non-specific diagnosis such as unspecified pneumonia or bronchiolitis. Hospital admission data alone can therefore not be used to accurately calculate the burden of RSV in secondary care.
Respiratory pathogens have varying temporal patterns which can be observed using laboratory surveillance data. Statistical models which utilise the seasonal variation in laboratory reports by pathogen can be constructed to attribute hospital admissions to different viruses. 4, 5 This method of estimating the hospital burden of RSV has previously been used in the UK; however, the most recent study only considers data up to 2009. [4] [5] [6] Surveillance of respiratory viruses including RSV has been strengthened in England since the 2009 influenza A (H1N1) pandemic, with more widespread use of laboratory confirmation for respiratory viruses with PCR methods, and a greater degree of reporting to national surveillance schemes. 7 In addition, a recent study in the UK demonstrates that hospital admission due to bronchiolitis is increasing over time. 8 These developments emphasise the need for more recent estimates of RSV-associated hospital admissions as previous estimates may not reflect the current burden of disease.
The aim of this work was to estimate the number of hospital admissions attributable to RSV in children <5 years of age in England in the period from mid-2007 to mid-2012 using ecological time series modelling of national laboratory surveillance and hospital administrative data.
| METHODS

| Data sources
| National laboratory reports
The Second Generation Surveillance System (SGSS)-formerly 
| Hospital Episode Statistics (HES)
The Hospital Episode Statistics (HES) admitted patient care database, held by the Health and Social Care Information Centre (HSCIC), contains routinely collected data on all admissions to all NHS hospitals in England. Records include clinical, geographical and administrative information including admission and discharge dates, on every patient.
In this analysis, an admission refers to a single HES spell-from admission to discharge in one hospital.
Diagnoses are recorded in HES using International Classification of were included in the study. Calendar weeks were defined as blocks of 7 days beginning on 1st January each year, with week 52 allowed to have more than 7 days. Only the primary diagnosis was included to avoid double counting of admissions which may have two or more of these diagnoses. HES data were not available for 2013 onwards. The weekly number of hospital admissions was stratified into three groups:
<6 months, 6-11 months and 1-4 years.
| Statistical analysis
In this study, we use the observed temporal variation in weekly laboratory reports of potential causative pathogens to estimate the number of RTI hospital admissions that could be attributed to RSV, building on methods applied in previous modelling studies. 4, 10, 11 Separate models were developed for each primary diagnosis, using the weekly number of hospital admissions in children <5 years of age in England for each respective diagnosis as the dependent variable. For each diagnosis, separate models were constructed by age group (<6 months, 6-11 months, 1-4 years).
Multiple linear regression models were used to estimate the number of hospital admissions due to RSV from HES data coded as acute bronchiolitis, pneumonia, unspecified LRTI, bronchitis and URTI.
These models have been used in similar studies. 4, 10, 12, 13 All models used the weekly number of laboratory-confirmed episodes in children 
| RESULTS
| Seasonality of laboratory reports and hospital admissions
The temporal variation in laboratory reports by pathogen is shown in Figure 1 . The temporal trends in hospital admissions for children <5 years old in England with a primary diagnosis of bronchiolitis, pneumonia, bronchitis, unspecified LRTI or URTI are shown in Figure 2 .
Hospital admissions with a primary diagnosis of bronchiolitis were markedly seasonal and mirror the pattern of laboratory-confirmed RSV infections. Hospital admissions with a primary diagnosis of pneumonia had a very similar seasonal pattern to hospital admissions with a primary diagnosis of unspecified LRTI, with peaks also occurring at the same time as the peaks in laboratory-confirmed RSV infections in SGSS each year (Figure 2 (Tables 1 and 2 ).
On average, the estimated admission rate of any RSV-associated RTI hospital admission was 35.1 (95% CI: 32.9-38.9) per 1000 children <1 year of age and 5.31 (95% CI: 4.5-6.6) per 1000 children 1-4 years of age, per epidemiological year (Table 3) . Estimated rates of RSV-associated hospital admissions were, on average, higher in <1-year-olds for all diagnoses except unspecified LRTI, where admission rates in 1-to 4-year-olds were higher (Table 3 ). All LRTI admission (Table 2) . During the period from calendar week 46 to week 2, over 90% of bronchiolitis admissions in children aged <6 months and over 80% in children aged 6-11 months and 1-4 years were attributable to RSV each week ( Figure 3 ). The other explanatory pathogens for bronchiolitis admissions were parainfluenza, hMPV and rhinovirus, with differences in causal pathogens by age (see Supplementary Data).
| LRTI admissions: bronchiolitis, pneumonia, bronchitis and unspecified LRTI
There was an annual average of 9537 hospital admissions with a primary diagnosis of pneumonia in children <5 years of age in
England from 2007 to 2012. We estimate that approximately 25%
(2346/9537, 95% CI: 22-27%) of these were due to RSV (Table 1 ).
There were differences by age, with approximately 26% (1923/7503, for hospital admissions with a primary diagnosis of pneumonia in children <5 years of age were S. pneumoniae, hMPV, parainfluenza, influenza A and rhinovirus, with differences in causal pathogens by age.
There was an annual average of 547 hospital admissions with a primary diagnosis of acute bronchitis in children <5 years of age in Table 2 ).
The other main explanatory pathogens for hospital admissions with a primary diagnosis of unspecified LRTI in children <5 years of age were adenovirus, S. pneumoniae, hMPV, parainfluenza, rhinovirus and influenza A, with differences in causal pathogens by age.
| URTI admissions
From 2007 to 2012, there was an annual average of 68 455 hospital admissions with a primary diagnosis of URTI in children <5 years of age in England. We estimate that approximately 8% (5450/68 455, 95% CI: 5-12%) of these were due to RSV (Table 1 ). There were no significant differences in the percentage of URTI admissions attributable to RSV by age group, although a slightly higher percentage of admissions in children <6 months of age were attributed to RSV (11%, 942/8868, 95% CI: 9-12%). The other explanatory pathogens for hospital admissions with a primary diagnosis of URTI were influenza A, parainfluenza and adenovirus.
The number of hospital admissions attributed to each pathogen in each final model is shown in Table S1 . Our study is the first to determine burden of RSV-associated respiratory hospital admissions in children in England according to primary diagnosis and age group. Our study uses smaller age groupings than previous studies to more precisely reflect the differences in RSV-associated illness by age. Our study is also the first to estimate T A B L E 3 Estimated admission rates of RSV-associated hospital admissions per 1000 children <5 y of age in England. T A B L E 2 Total RTI hospital admissions estimated to be due to RSV by the final models, stratified by age group (<6 mo, 6-11 mo, 1-4 y) and primary diagnosis, as a percentage of the total hospital admissions for the respective primary diagnosis and the annual number of hospital admissions due to bronchiolitis in young children in the UK has also increased sevenfold between 1979 and 2011. 8, 19 This evidence suggests that the increase is not due to an increase in the severity of infection, nor the virulence of RSV in the age group, because paediatric intensive care admission rates have changed little from 2004 to 2012. 8 Instead, these trends are likely due to a general increase in hospital admission, potentially due to hospital admission thresholds being lowered (particularly in the younger infants) or failure to manage these acute illnesses in the community care setting. 20 Our study found a high burden of RSV-associated hospital admissions in children <6 months of age, a group well documented as being at high risk of RSV-associated hospital admission. 21 However, our study also found a high number of RSV-associated pneumonia and unspecified LRTI admissions in children aged 1-4 years. RSV was the pathogen associated with the highest number of admissions for all types of LRTI in all age groups compared to the other pathogens, except for pneumonia and unspecified LRTI in children aged <6 months F I G U R E 3 Percentage of total weekly hospital admissions due to RSV for each primary diagnosis, by age group 
| DISCUSSION
